# Crestview Pharma, LLC – FDA Inspection, Jul 13, 2017

Source: https://www.keypedia.com/records/fda_inspections/crestview-pharma-llc/88f33768-e432-4743-838e-7cd7551e0f0b
Source feed: FDA_Inspections

> FDA inspection 1020411 of Crestview Pharma, LLC, July 13, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1020411
- Company Name: Crestview Pharma, LLC
- Inspection Date: 2017-07-13
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/annette-melendez/bc1a065d-6408-4c4b-9dcf-c6884e8a75c4)

Company: https://www.keypedia.com/companies/crestview-pharma-llc/f7893064-ca4a-48fc-b1a8-18011a3ec355

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d